Avalyn Pharma Inc. Common Stock (AVLN) — Net Asset Quality Index
Avalyn Pharma Inc. Common Stock (AVLN) has a Net Asset Quality Index of 93.6% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $425.45 Million minus total liabilities of $27.10 Million yields net assets of $398.35 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read Avalyn Pharma Inc. Common Stock balance sheet liabilities for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Avalyn Pharma Inc. Common Stock Net Asset Quality Index Over Time (2024–2025)
This chart shows how Avalyn Pharma Inc. Common Stock's Net Asset Quality Index has evolved across 2 annual periods from 2024 to 2025. As of June 2026, the index stands at 93.6%, representing net assets of $398.35 Million against total assets of $425.45 Million USD. For live market cap and overall valuation, see AVLN market cap overview.
Annual Net Asset Quality Index for Avalyn Pharma Inc. Common Stock (2024–2025)
The table below presents the year-by-year Net Asset Quality Index for Avalyn Pharma Inc. Common Stock from 2024 to 2025, covering 2 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check Avalyn Pharma Inc. Common Stock strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | -160.3% | $-238.66 Million | $148.88 Million | $387.54 Million | ▼ -20.1 pp |
| 2024 | -140.2% | $-174.52 Million | $124.52 Million | $299.04 Million | — |